Multichannel
Seizing the moment in digital
One of the most remarkable changes driven by the pandemic has been the rapid transition from face-to-face interaction to...
Multichannel
Digital success doesn’t start with the tech
We all know that the biggest hurdle for any transformation project is culture. No wonder then that many of us working within...
Latest
-
Patients and MedicalInnovation to enable care from the comfort of home is gathering momentum but implementing it in practice is complex
-
Patients and Medical
PED: Turning the patient voice into a dataset
Patients and pharma are teaming up to capture valuable patient experience data and they are only getting started -
Multichannel
Making strategic sense of pharma’s new race for competitive advantage
The race for competitive advantage for pharma today is about far more than just innovative new molecules. -
Multichannel
Connected HCP experiences: The holy grail of precision marketing
Still stuck in multichannel and too often serving up undifferentiated messaging, pharma has much to do to understand and serve individual HCPs -
Multichannel
Wired for success in omnichannel
Marcomms has much to gain by nurturing a closer working relationship with IT colleagues
Most Popular
Andrew Stone, (May 16, 2023)
Innovation to enable care from the comfort of home is gathering momentum but implementing it in practice is complex
Lucy Fisher, (Jun 2, 2023)
Pharma companies should zero in on commonalities between functions to achieve a genuine customer-centric omnichannel
Opinion
Jill Donahue, (Mar 16, 2023)
For Zena Sfeir, Aitia VP Marketing, a strong sense of purpose is key to making an impact and improving lives

Jill Donahue, (Sep 5, 2022)
For Ana Paula Carvalho, President of Western Europe Cluster, Pfizer, her purpose began amidst overcoming challenges.

Commercial
-
Building a commercial dream team for today’s pharma industry
The transformation in the way pharma and HCPs interact is leading pharma companies to reorganize and rethink the makeup and approach of its commercialization teams -
Omnichannel: How will pharma get there?
The journey from multichannel to omnichannel requires closer data co-ordination, an agile approach, new metrics and nimbler content management -
Becoming agile in experience measurement
The customer experience is pharma’s new competitive battleground – trust is its key metric, and the prizes will go to the nimble -
Paving the payment path for DTx
The digital therapeutics reimbursement process is maturing but complexity and risk remain to be managed -
The field force: Is small beautiful?
As big pharma ponders the right sizing of its post-pandemic field forces, can it learn from smaller, leaner industry peers about doing more with less?
Access and Evidence
-
RWE’s new dataset: Social media
Pharma is waking up to the potential of social media to enhance existing RWD sources and to offer altogether new insights in rare disease and beyond -
How automation is changing regulatory affairs
Post pandemic, pharma and regulators are both working to accelerate the transformative power of electronic filing -
An early peek at the FDA’s RWE ‘cookbook’
The FDA is developing guidelines that will help pharma accelerate its adoption of RWE, this is what the industry should know -
The future is bright for RWE in pharma approvals
The FDA and other regulatory bodies are increasingly willing to accept real-world evidence as part of approvals. Pharma is up to the task -
Payers and the ABCs of digital literacy
Convincing payers of the value of digital add-ons and of drug/device combinations requires pharma to demonstrate that patients and other stakeholders understand how to use them
Patients and Medical
-
Moving care from hospital to home
Innovation to enable care from the comfort of home is gathering momentum but implementing it in practice is complex -
PED: Turning the patient voice into a dataset
Patients and pharma are teaming up to capture valuable patient experience data and they are only getting started -
Advocacy in hemophilia: Crafting a path that leaves no-one behind
Implementing an ethical and realistic global access strategy for hemophilia so that patients everywhere can receive treatment -
Digital Health: Letting human nature drive design
End users are increasingly important partners in developing digital health solutions, to the benefit of all -
Advancing health equity for the LGBTQIA+ community
Marginalised and with a range of unmet health needs, LGBTQIA+ patients are not getting the care they need. Pharma can help.